Filling and freeze-drying drivers for $950m Cook deal says Catalent

By Gareth Macdonald contact

- Last updated on GMT

Filling and freeze-drying drivers for $950m Cook deal says Catalent

Related tags: Syringe

Catalent has cited Cook’s ability to make and freeze-dry liquid drugs as major drivers for its planned takeover and said it is keen to take on the firm’s biopharma customers.

The New Jersey, US contractor announced its intention to buy Cook Pharmica on Tuesday​, explaining the $950m (€794m) deal is designed to expand its biopharmaceutical manufacturing and bioanalysis capabilities.

A Catalent spokesman expanded on this, telling us “There are areas where Cook Pharmica brings additional capabilities, for example in handling liquid and lyophilized vials as well as syringes and cartridges, but Cook Pharmica is attractive for many reasons​.”

He cited Cook’s facility in Bloomington, Indiana as key, explaining “its vial and pre-filled syringe lines are fully automated and meet the latest customer and regulatory needs.

“Its biomanufacturing operations are designed to handle a wide range of batch sizes too, similar to what we’ve been able to achieve in Madison, Wisconsin​.”

The spokesman also said customer demand had played a part in driving the acquisition, adding that Cook “has the capabilities and capacity that biologics customers find attractive when choosing a partner​.”

From a capacity standpoint, Bloomington has available expansion space to efficiently support future growth​” he said.

Catalent is also keen to take on contracts with existing Cook customers according to the spokesman.

He said: “Until the acquisition is finalised, we will continue to operate as separate businesses.

Catalent Biologics will work with Cook Pharmica and its customers to maintain existing relationships and ensure minimal customer impact​.”

Related news

Show more

Related products

Fill-Finish Biologics

Fill-Finish Biologics

Curia | 16-May-2022 | Technical / White Paper

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars